Global breast cancer diagnostics and therapeutics market are estimated to grow significantly at a CAGR of 9.4% during the forecast period. The growth of the market is attributed to the increasing prevalence of breast cancer and rising awareness in emerging countries such as India, China, and Malaysia. Furthermore, the introduction of new technology such as imaging technology and 3D mammography is also estimated to have a significant impact on the growth of the market. The global expenditure on breast cancer therapies and medicines is increasing very rapidly which leads to the high rates of diagnosis and treatment of breast cancer. However, the high cost of breast cancer drugs and surgeries across the developed countries are estimated to be the major constraints in the growth of the market. As per the American Cancer Society, breast cancer treatment can cost more than $100,000 in developed countries such as the US. The lack of awareness in women about breast cancer in developing countries is retraining the market.
To Request a Sample of our Report on Global Breast Cancer Diagnostics And Therapeutics Market: https://www.omrglobal.com/request-sample/breast-cancer-diagnostics-therapeutics-market
Global breast cancer diagnosis and therapeutics market are segmented on the basis of cancer type, diagnostics, and therapeutics. In cancer type segment market is further classified into ductal carcinoma in-situ (DCIS), invasive ductal carcinoma (IDC), triple negative breast cancer (TNBC), inflammatory breast cancer and others. In diagnostics technology, the segment market is further classified into mammography, biopsy, position emission tomography/Computed tomography, ultrasound, and others. The therapeutics technology segment market is further segregated into chemotherapy, hormone therapy, targeted therapy, and others.
(Get 15% Discount on Buying this Report)
A full Report of Global Breast Cancer Diagnostics And Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/breast-cancer-diagnostics-therapeutics-market
Global Breast Cancer Diagnostics And Therapeutics Segmentation
By Cancer Type
- Ductal Carcinoma In-Situ (DCIS)
- Invasive Ductal Carcinoma (IDC)
- Triple Negative Breast Cancer (TNBC)
- Inflammatory Breast Cancer
- Others (Invasive lobular carcinoma)
By Diagnostics
- Mammography
- Biopsy
- PET/CET
- Ultrasound
- Others (MRI)
By Therapeutics
- Chemotherapy
- Hormone Therapy
- Targeted Therapy
- Others (Radiation Therapy, Surgery)
Regional Analysis
- North America
- United States
- Canada
Europe
- UK
- Germany
- Italy
- Spain
- France
Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
Rest of the World
Company Profiles
- AbbVie Inc.
- Agendia NV
- AstraZeneca PLC
- Astellas Pharma Inc.
- Bayer AG
- Bristol-Myers Squibb Co
- Eisai Co., Ltd.
- Eli Lilly and Co.
- GlaxoSmithKline PLC
- Halozyme, Inc
- Hologic Inc.
- Johnson & Johnson Services Inc.
- Merck & Co., Inc.
- Mylan NV
- 7Novartis International AG
- Pfizer Inc.
- F. Hoffmann-La Roche AG
- Sanofi S.A.
- Siemens Healthcare GmbH
- Takeda Pharmaceutical Co. Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
